Amgen Inc. (AMGN) vs Eli Lilly and Company (LLY)
A side-by-side comparison of Amgen Inc. and Eli Lilly and Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 30, 2026. Differences are shown without an overall score or investment verdict.
AMGN
Amgen Inc.
$382.16HealthcareDelayed quote: Jul 30, 2026, 12:10 PM EDT
LLY
Eli Lilly and Company
$1,162.00HealthcareDelayed quote: Jul 30, 2026, 12:10 PM EDT
Total return — AMGN vs LLY
growth of $100 · dividends reinvested · last 30yAMGN +4255.9%LLY +9308.2%LLY compounded faster
AMGN LLY
AMGN vs LLY: by the numbers
- •LLY is the larger company ($1.09T vs $206.26B market cap).
- •AMGN trades at the lower trailing earnings multiple (26.98 vs 42.98 P/E), one valuation lens rather than an overall verdict.
- •LLY converts more revenue to profit (34.98% vs 20.95% net margin).
- •LLY grew revenue faster over the past five years (23.17% vs 8.15% CAGR).
- •AMGN pays the higher dividend yield (2.53% vs 0.53%).
Metrics side by side
Valuation
| Metric | AMGN | LLY |
|---|---|---|
| P/E ratio | 26.98 | 42.98 |
| Forward P/E | 17.34 | 34.45 |
| P/S ratio | 5.66 | 15.00 |
| P/B ratio | 22.95 | 34.75 |
| PEG ratio | 0.26 | 0.49 |
| EV / EBITDA | 15.36 | 32.30 |
| FCF yield | 4.08% | 1.25% |
Profitability
| Metric | AMGN | LLY |
|---|---|---|
| Gross margin | 71.46% | 83.51% |
| Operating margin | 31.63% | 45.87% |
| Net margin | 20.95% | 34.98% |
| ROE | 84.87% | 81.01% |
| ROIC | 13.16% | 30.20% |
Dividends
| Metric | AMGN | LLY |
|---|---|---|
| Dividend yield | 2.53% | 0.53% |
| Payout ratio | 68.39% | 28.09% |
Growth (annualized)
| Metric | AMGN | LLY |
|---|---|---|
| Revenue CAGR (5Y) | 8.15% | 23.17% |
| EPS CAGR (5Y) | 2.94% | 28.88% |
| FCF CAGR (5Y) | -2.66% | 19.54% |
| Total return CAGR (5Y) | 13.36% | 38.90% |
Frequently asked
- Which has the lower trailing P/E, AMGN or LLY?
- AMGN has the lower trailing P/E: AMGN trades at 26.98 and LLY at 42.98. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, AMGN or LLY?
- Over the past five years, LLY grew revenue faster — AMGN at a 8.15% CAGR versus LLY at 23.17%.
- Does AMGN or LLY pay a bigger dividend?
- AMGN yields 2.53% and LLY yields 0.53% based on trailing dividends and the latest price.
- Is AMGN or LLY more profitable?
- LLY runs the higher net margin — AMGN at 20.95% versus LLY at 34.98%.
- How have AMGN and LLY total returns compared?
- Over the past 10 years, AMGN delivered 11.74% and LLY delivered 32.88% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Amgen P/E ratioEli Lilly and P/E ratioAmgen dividend yieldEli Lilly and dividend yieldAmgen ROEEli Lilly and ROEAmgen operating marginEli Lilly and operating marginAmgen revenue growthEli Lilly and revenue growthAmgen free cash flowEli Lilly and free cash flow
Amgen & Eli Lilly and appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 30, 2026.